Skip to main content
Figure 2 | BMC Infectious Diseases

Figure 2

From: Weekly use of fluconazole as prophylaxis in haematological patients at risk for invasive candidiasis

Figure 2

Susceptibility* of invasive Candida isolates to fluconazole from 2003–2012. Light grey bars = percentage of susceptible Candida species. *Susceptibility is defined as a minimum inhibitory concentration (MIC) of < or equal to 8 mg/L (CLSI definition, 2008). CLSI = Clinical and Laboratory Standards Institute, formerly known as the National Committee for Clinical Laboratory Standards (NCCLS).

Back to article page